Showing results (41-50 of 86) with videos related to
Sort By:
Pageof 9
Frontiers in Immunology|December 5, 2022
Age-dependent NK cell dysfunctions in severe COVID-19 patientsCinzia Fionda, Silvia Ruggeri, Giuseppe Sciumè, et al.Biomedicines|July 27, 2024
Sarcoidosis versus Granulomatous and Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency: A Comparative ReviewHelena Buso, Claudia Discardi, Patrick Bez, et al.Plos One|March 4, 2021
Subcutaneous immunoglobulins replacement therapy in secondary antibody deficiencies: Real life evidence as compared to primary antibody deficienciesFrancesco Cinetto, Raffaella Neri, Fabrizio Vianello, et al.Clinical Immunology (Orlando, Fla.)|February 5, 2022
Subcutaneous Gammanorm® by pump or rapid push infusion: Impact of the device on quality of life in adult patients with primary immunodeficienciesKlaus Warnatz, Stephen Jolles, Carlo Agostini, et al.Journal of Clinical Immunology|January 16, 2019
Health-Related Quality of Life in Patients with CVID Under Different Schedules of Immunoglobulin Administration: Prospective Multicenter StudyFederica Pulvirenti, Francesco Cinetto, Antonio Pecoraro, et al.Frontiers in Immunology|October 23, 2023
Decline of gastric cancer mortality in common variable immunodeficiency in the years 2018-2022Cinzia Milito, Federica Pulvirenti, Giulia Garzi, et al.Frontiers in Immunology|November 13, 2023
SARS-CoV-2 pre-exposure prophylaxis with tixagevimab/cilgavimab (AZD7442) provides protection in inborn errors of immunity with antibody defects: a real-world experienceFederica Pulvirenti, Giulia Garzi, Cinzia Milito, et al.The Journal of Infectious Diseases|November 8, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Combination Therapy in Patients With Coronavirus Disease 2019 and Primary Antibody DeficiencyFederica Pulvirenti, Cinzia Milito, Francesco Cinetto, et al.Biomedicines|May 28, 2022
Mortality in Severe Antibody Deficiencies Patients during the First Two Years of the COVID-19 Pandemic: Vaccination and Monoclonal Antibodies EfficacyCinzia Milito, Francesco Cinetto, Andrea Palladino, et al.Cells|June 24, 2022
T-Cell Defects Associated to Lack of Spike-Specific Antibodies after BNT162b2 Full Immunization Followed by a Booster Dose in Patients with Common Variable Immune DeficienciesFederica Pulvirenti, Stefano Di Cecca, Matilde Sinibaldi, et al.Pageof 9